LYPLAL1 and metabolic dysfunction-associated steatotic liver disease: In this study, the genetic polymorphisms of NCAN rs2228603, GCKR rs780094, PPP1R3B rs4240624 and LYPLAL1 rs12137855 were not associated with NAFLD in contrast to the results of previous European and American studies [21, 22].